Literature DB >> 28004195

The periprostatic venous plexus: an unusual source of fatal pulmonary embolism during corporoplasty.

Nazario Foschi1, Mauro Ragonese1, Vincenzo M Grassi2, Valentino De Matteis2, Fabio De-Giorgio3.   

Abstract

When a sudden death occurs during a minor surgical intervention, it may require a careful and extensive postmortem investigation. One such case concerns a 61-year-old male patient affected by Peyronie's disease, who died suddenly during a corporoplasty procedure. Autopsy and histologic examinations showed a massive bilateral pulmonary micro-embolism brought on by periprostatic venous plexus thrombosis. The cause of death was attributed to intraoperative fatal pulmonary micro-embolism. Pulmonary thromboembolism is a major cause of death and is known to be a possible complication of surgery. Nevertheless, the periprostatic venous plexus is an unusual site of thrombosis, as it has been demonstrated that the majority of emboli originate in the legs. In this case, the embolism was massive and fatal and occurred during a minor surgical procedure, even though the patient was not at risk for venous thromboembolism, nor did he have a significant past medical history.

Entities:  

Keywords:  Fatal pulmonary embolism; Forensic autopsy; Periprostatic venous plexus thrombosis; Sudden death

Mesh:

Year:  2016        PMID: 28004195     DOI: 10.1007/s00414-016-1519-9

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  16 in total

Review 1.  Penile corporoplasty in Peyronie's disease: which technique, which graft?

Authors:  Rados Djinovic
Journal:  Curr Opin Urol       Date:  2011-11       Impact factor: 2.309

2.  Failure to awaken after general anaesthesia secondary to paradoxical venous embolus.

Authors:  S Liu; H S Holley; S D Stulberg; B Cohen
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

3.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

Authors:  O V Batson
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

Review 4.  Treatment of Peyronie's disease: 2012 update.

Authors:  Ege Can Serefoglu; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

5.  Frequency of thrombi in prostatic venous plexus in an autopsy series.

Authors:  S Ljungerud; A Ljungh; A Rausing
Journal:  Acta Chir Scand       Date:  1973

Review 6.  Perioperative pulmonary embolism: diagnosis and anesthetic management.

Authors:  Matthew C Desciak; Donald E Martin
Journal:  J Clin Anesth       Date:  2011-03       Impact factor: 9.452

7.  A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

Authors:  Robert J Glynn; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Paul M Ridker
Journal:  N Engl J Med       Date:  2009-03-29       Impact factor: 91.245

Review 8.  Operative and Perioperative Pulmonary Emboli.

Authors:  Jordy C Cox; David M Jablons
Journal:  Thorac Surg Clin       Date:  2015-06-12       Impact factor: 1.750

9.  Postmortem demonstration of the source of pulmonary thromboembolism: the importance of the autopsy.

Authors:  Gina Elhammady; Andrew T Schubeck; Vicky El-Najjar; Morton J Robinson
Journal:  Case Rep Vasc Med       Date:  2011-10-18

10.  Hospital Episode Statistics data analysis of postoperative venous thromboembolus in patients undergoing urological surgery: a review of 126,891 cases.

Authors:  J Dyer; S Wyke; C Lynch
Journal:  Ann R Coll Surg Engl       Date:  2013-01       Impact factor: 1.891

View more
  1 in total

1.  The application of autophagy to thrombus age estimation in murine deep vein thrombosis model.

Authors:  Mizuho Nosaka; Yuko Ishida; Yumi Kuninaka; Akira Taruya; Akihiko Kimura; Emi Shimada; Hiroki Yamamoto; Tomomi Michiue; Fukumi Furukawa; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2019-11-12       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.